New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease

Published:2019-03-15 Issue:3 Volume:91 Page:76-85
ISSN:2309-5342
Container-title:Terapevticheskii arkhiv
language:
Short-container-title:Terapevticheskii arkhiv

Author:

Avdeev S N,Trushenko N V

Abstract

Currently, combinations of long-acting beta2-agonists and long-acting anticholinergics are considered as the basic therapy for majority of patients with chronic obstructive pulmonary disease (COPD). These combinations have different pharmacological characteristics and delivery devices that provides different clinical effects and new opportunities for personalized treatment of COPD. Aclidinium/formoterol fixed combination differs from other dual bronchodilators by twice-daily dosing regimen, good safety profile and a specific delivery system. Recent information on clinical efficacy and safety of aclidinium/formoterol combination in COPD patients is given in this article.

Publisher

Consilium Medicum

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice

Link

https://ter-arkhiv.ru/0040-3660/article/viewFile/33018/pdf

Reference63 articles.

1. GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Updated 2018. Available from http://www.goldcopd.org/

2. Авдеев С.Н., Трушенко Н.В. Двойная бронходилатация - новая парадигма длительно терапии хронической обструктивной болезни легких. Практическая пульмонология. 2015;3:24-32.

3. Ford E.S. Hospital discharges. readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and nationwide emergency department sample 2006-2011. Chest. 2015;147:989-98.

4. Ingebrigtsen T.S, Marott J.L, Nordestgaard B.G, et al. Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med. 2015;30:51-9.

5. Bender B.G. Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should we do next? Curr Opin Pulm Med. 2014;20:132-7.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary rehabilitation of chronic pulmonary diseases (the review of clinical trials, national and international recommendations);Journal of Clinical Practice;2022-10-26

2. Features and significance of the early bronchodilatation effect of the first dose of a long-acting bronchodilator alone and in fixed combination in the treatment of chronic obstructive pulmonary disease;Bulletin of the Russian Military Medical Academy;2022-04-20

3. The double bronchodilation era: new capabilities in a new drug delivery device;Meditsinskiy sovet = Medical Council;2022-04-06

4. Pulmonary Rehabilitation of Chronic Obstructive Pulmonary Diseases (Review of Clinical Trials, National and International Recommendations);Bulletin of Restorative Medicine;2020-10-29